0 CHECKOUT

NRT Smoking Cessation Aids in Australia

  • ID: 342827
  • June 2015
  • Region: Australia
  • 19 Pages
  • Euromonitor International

In 2014, as many as 2.7 million Australian smokers had the intention to quit within a 12 month time frame. This resulted in an increase in demand for smoking cessation aids in 2014, with the most popular category remaining patches, with a 45% value share in NRT smoking cessation aids. However, trade sources suggest that nicotine patches will decrease in prominence in the forecast period compared with other NRT products.

The NRT Smoking Cessation Aids in Australia report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2010-2014, allowing you to identify the sectors driving growth. Forecasts to 2019 illustrate how the market is set to change.

Product coverage: NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
- Get a detailed picture of the NRT Smoking Cessation Aids market;
- Pinpoint growth sectors and identify factors driving change;
- Understand the competitive environment, the market’s major players and leading brands;
- Use five-year forecasts to assess how the market is predicted to develop.

Note: Product cover images may vary from those shown

NRT SMOKING CESSATION AIDS IN AUSTRALIA

June 2015

LIST OF CONTENTS AND TABLES

Headlines
Trends
Competitive Landscape
Prospects
Category Indicators
Table 1 Number of Smokers by Gender 2009-2014
Category Data
Table 2 Sales of NRT Smoking Cessation Aids by Category: Value 2009-2014
Table 3 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2009-2014
Table 4 Sales of NRT Gum by Flavour: % Value Breakdown 2009-2014
Table 5 NBO Company Shares of NRT Smoking Cessation Aids: % Value 2010-2014
Table 6 LBN Brand Shares of NRT Smoking Cessation Aids: % Value 2011-2014
Table 7 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2014-2019
Table 8 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2014-2019
Executive Summary
Consumer Health Registers Slower Growth in 2014
the Ageing Population Remains A Key Growth Driver
Swisse Wellness Led Overall Consumer Health in 2014
Growth of Parapharmacies/drugstores
Growth Expected To Slow Over the Forecast Period
Key Trends and Developments
Growing Influence of Private Label
Regulations Inhibit Growth
Parapharmacy/drugstore Price-cutters
Market Indicators
Table 9 Consumer Expenditure on Health Goods and Medical Services: Value 2009-2014
Table 10 Life Expectancy at Birth 2009-2014
Market Data
Table 11 Sales of Consumer Health by Category: Value 2009-2014
Table 12 Sales of Consumer Health by Category: % Value Growth 2009-2014
Table 13 NBO Company Shares of Consumer Health: % Value 2010-2014
Table 14 LBN Brand Shares of Consumer Health: % Value 2011-2014
Table 15 Penetration of Private Label in Consumer Health by Category: % Value 2009-2014
Table 16 Distribution of Consumer Health by Format: % Value 2009-2014
Table 17 Distribution of Consumer Health by Format and Category: % Value 2014
Table 18 Forecast Sales of Consumer Health by Category: Value 2014-2019
Table 19 Forecast Sales of Consumer Health by Category: % Value Growth 2014-2019
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
Sources
Summary 1 Research Sources

Note: Product cover images may vary from those shown

- Blackmores Ltd
- Ego Pharmaceuticals Pty Ltd
- Herron Pharmaceuticals Pty Ltd
- Inova Pharmaceuticals (australia) Pty Ltd
- Swisse Natural Health Products Pty Ltd

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

PLEASE SELECT A FORMAT

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a single user license, allowing one specific user access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is a site license, allowing all users within a given geographical location of your organisation access to the product.

  • Quick Help: The report will be emailed to you. The report is sent in PDF format. This is an enterprise license, allowing all employees within your organisation access to the product.

HAVE A QUESTION?

If you have a more general question about our products please try our

FAQ SECTION

RELATED PRODUCTS

Our Clients

  • Johnson & Johnson Services, Inc.
  • Procter & Gamble Co.
  • Sanofi S.A.
  • GlaxoSmithKline PLC
  • Novartis AG
  • Pfizer, Inc.
  • Boehringer Ingelheim GmbH